Literature DB >> 8006199

Disposition of clozapine and desmethylclozapine in schizophrenic patients.

S K Lin1, W H Chang, M C Chung, Y W Lam, M W Jann.   

Abstract

The disposition of the atypical clozapine and its desmethyl metabolite were evaluated in fourteen male chronic patients. A single 100 mg dose of clozapine was administered and blood sampling performed over the following 72 hours. The mean (SD) oral clearance and half-life of clozapine were 55.4 (29.7) L/hr and 13.7 (9.9) hours, respectively. The mean (SD) AUC for clozapine and desmethylclozapine was 2389.9 (1406) and 751.1 (622.9) ng.hr/mL, respectively. The elimination of the metabolite is rate limited by its formation from cloza-pine. A wide interpatient variability in clozapine and desmethylclozapine pharmacokinetics was observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006199     DOI: 10.1002/j.1552-4604.1994.tb02000.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  5 in total

1.  Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.

Authors:  Li-jun Li; De-wei Shang; Wen-biao Li; Wei Guo; Xi-pei Wang; Yu-peng Ren; An-ning Li; Pei-xin Fu; Shuang-min Ji; Wei Lu; Chuan-yue Wang
Journal:  Acta Pharmacol Sin       Date:  2012-07-23       Impact factor: 6.150

2.  Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.

Authors:  M Fabrazzo; G Esposito; R Fusco; M Maj
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

3.  Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice.

Authors:  José L Moreno; Terrell Holloway; Adrienne Umali; Vinayak Rayannavar; Stuart C Sealfon; Javier González-Maeso
Journal:  Psychopharmacology (Berl)       Date:  2012-07-28       Impact factor: 4.530

4.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

5.  A Kinetic Model for Simultaneous Fit of Clozapine and Norclozapine Concentrations in Chronic Schizophrenic Patients during Long-Term Treatment.

Authors:  C Guitton; J M Kinowski; R Gomeni; F Bressolle
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.